A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Febuxostat (Primary) ; Allopurinol
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- Acronyms APEX
- Sponsors TAP Pharmaceutical Products
- 05 Nov 2010 New trial record.
- 01 Nov 2005 Results presented at the 69th Annual Scientific Meeting of the American College of Rheumatology and the 40th Annual Meeting of the Association of Rheumatology Health Professionals.